Aimmune Sets In $145M Nestlé Health Equity Investment

Aiming to continue the expansion of the biotech sphere and looks to boost its food-allergy programs, Nestlé Health Science has financed $145 million into Aimmune ($AIMT).

Read Full Article

Bayer Shares was Lifted as Monsanto's Interest in Crop Science Business

Shares of the German pharmaceutical and chemical giant increased by 5% in Monday trading. Monsanto's interest to acquire its crop science business triggered the surge.

Read Full Article

Korean Venture Capital Firms Gaze at Overseas Biotech Companies

South Korean venture capital firms are eyeing overseas biotech industry to accelerate investment goals. At the sametime, tech startups in Korea also began to flourish.

Read Full Article

Biotech Accelerator IndieBio Is Convincing Investors to Start Paying Attention to Biotech Startups

San Fransisco-based biotech accelerator IndieBio is determined to help biotech startups the way other accelerators have done for IT startups. The firm believes that biotech is a highly important sector to boost the quality of humanity and economy, and is convincing other investors to have the same vision.

Read Full Article

China launches media campaign to back genetically modified crops

China's government has kicked off a media campaign in support of genetically modified crops, as it battles a wave of negative publicity over a technology it hopes will play a major role in boosting its food security.

Read Full Article

Hundreds of firms join global hunt for copycat biotech drugs

Hundreds of companies around the world are chasing an emerging market for cheaper copies of costly biotech drugs, with more than 700 so-called biosimilars now in development or already approved, according to a major study of the sector.

Read Full Article

San Francisco-based Benchling offers DNA editing software for biotech labs, researchers

Benchling, a startup backed by YCombinator, SV Angel, Founders Fund, Draper Associates and other angels, bridges biotechnology and computer science with their DNA editing software.

Read Full Article

Billion dollar valuations of newly-public biotech firms entice others to IPO

Biotech companies are in a rush to go public partly due to the sky-high valuations now experienced by many biotech firms that have gone public in the past few years, the Venture Capital Dispatch reported.

Read Full Article

23andMe to sell genetic information for US$99

The personal genomic and biotechnology corporation in the US would target people's DNA by selling their genetic information for US$99.

Read Full Article

Investments pour into Biotech Corp

Biotech Corp said that it has already passed its investment target for this year.

Read Full Article

Biotech firm Conatus raises $66-M in IPO

Conactus Pharmaceutical raised US $66 million after the company offered 6,000,000 shares at US $11 each during the initial public offering.

Read Full Article

Cleveland BioLabs moves drug development to Russia

Cleveland BioLabs and other biotech firms have stated their desire to move their development operations to Russia.

Read Full Article

Heliae Newest Funding Round Raises US$28.4 Million

Heliae raise US$28.4 million from current and new investors to promote algae-based specialty merchandises.

Read Full Article

Blue Sky BioServices appoints new Pres and CEO

Edward (Ted) Marple takes the lead of the research organization as its founder Paul Wengender focus on the business aspect.

Read Full Article

Singapore firm invests in Celltrion

Temasek Holdings from Singapore pledged to invest into Celltrion.

Read Full Article
1 2

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics